Fate of MHC-matched corneal allografts in Th1-deficient hosts

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 4, 2004, Pages 1188-1193

  Hargrave, Sylvia L ^a   Hay, Christina ^a   Mellon, Jessamee ^a   Mayhew, Elizabeth ^a   Niederkorn, Jerry Y ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPY; CELL INFILTRATION; CONTROLLED STUDY; CORNEA; CROSS REACTION; EOSINOPHIL; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY; HOST; IMMUNE RESPONSE; KERATOCONUS; KERATOPLASTY; KNOCKOUT MOUSE; MINOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK; TH1 CELL; WILD TYPE; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; DELAYED HYPERSENSITIVITY; GENETICS; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE MUTANT; NEW ZEALAND BLACK MOUSE; PENETRATING KERATOPLASTY; SKIN TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CORNEA; FEMALE; GRAFT REJECTION; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; KERATOPLASTY, PENETRATING; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MICE, INBRED NZB; MICE, KNOCKOUT; SKIN TRANSPLANTATION; TH1 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 2142702293     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0515     Document Type: Article

References (30)

1. Niederkorn JY. Immunology and immunomodulation of corneal transplantation. Int Rev Immunol. 2000;21:173-196.
2. Niederkorn JY. The immune privilege of corneal allografts. Transplantation. 1999;67:1503-1508.
3. Völker-Dieben HJ, Claas FH, Schreuder GM, et al. Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation. 2000;70:640-648.
4. Batchelor JR, Casey TA, Werb A, et al. HLA matching and corneal grafting. Lancet. 1976;1:551-554.
5. Völker-Dieben HJ, Kok-van Alphen CC, Lansbergen Q, Persijn GG. Different influences on corneal graft survival in 539 transplants. Acta Ophthalmol (Copenh). 1982;60:190-202.
6. Völker-Dieben HJ, Schreuder GM, Claas FH, et al. Histocompatibility and corneal transplantation. Dev Ophthalmol. 2003;36:22-41.
7. Reinhard T, Bohringer D, Enczmann J, et al. HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. Dev Ophthalmol. 2003;36:42-49.
8. Group CCTSR. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol. 1992;110:1392-1403.
9. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694-704.
10. He YG, Niederkorn JY. Depletion of donor-derived Langerhans cells promotes corneal allograft survival. Cornea. 1996;15:82-89.
11. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol. 1994;6:757-764.
12. Joo CK, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci. 1995;36:1530-1540.
13. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol. 1993;150:1727-1734.
14. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 1991;32:2723-2728.
15. Ayliffe W, Alam Y, Bell EB, McLeod D, Hutchinson IV. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol. 1992;76:602-606.
16. Yamada J, Yoshida M, Taylor AW, Streilein JW. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes. J Immunol. 1999;162:5247-5255.
17. She SC, Steahly LP, Moticka EJ. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg. 1990;21:781-785.
18. Ksander BR, Sano Y, Streilein JW. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes. Transpl Immunol. 1996;4:49-52.
19. Echtenacher B, Freudenberg MA, Jack RS, Mannel DN. Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun. 2001;69:7271-7276.
20. Hegde S, Niederkorn JY. The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci. 2000;41:3341-3347.
21. Niederkorn J, Streilein JW, Shadduck JA. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest Ophthalmol Vis Sci. 1981;20:355-363.
22. Peeler JS, Niederkorn JY. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J Immunol. 1986;136:4362-4371.
23. Callanan DG, Luckenbach MW, Fischer BJ, Peeler JS, Niederkorn JY. Histopathology of rejected orthotopic corneal grafts in the rat. Invest Ophthalmol Vis Sci. 1989;30:413-424.
24. Golovkina TV, Shlomchik M, Hannum L, Chervonsky A. Organogenic role of B lymphocytes in mucosal immunity. Science. 1999;286:1965-1968.
25. Niederkorn JY, Peeler JS, Mellon J. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg Immunol. 1989;2:83-90.
26. Hargrave S, Chu Y, Mendelblatt D, Mayhew E, Niederkorn J. Preliminary findings in corneal allograft rejection in patients with keratoconus. Am J Ophthalmol. 2003;135:452-460.
27. Matesic D, Valujskikh A, Pearlman E, Higgins AW, Gilliam AC, Heeger PS. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. J Immunol. 1998;161:5236-5244.
28. Bishop DK, Chan Wood S, Eichwald EJ, Orosz CG. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. J Immunol. 2001;166:3248-3255.
29. Wang S, Fan Y, Brunham RC, Yang X. IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol. 1999;29:3782-3792.
30. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993;44:85-101.